impairment
mucociliary
transport
cystic
fibrosis
past
years
studies
various
laboratories
suggested
presence
factor
cystic
fibrosis
serum
causing
widespread
vitro
abnormalities
components
lung
defence
mechanism
particularly
respect
macrophage
dysfunction
quantitative
qualitative
alterations
mucus
ciliary
motility
possible
vivo
role
ciliary
dysfunction
pathogenesis
disease
particular
clinical
interest
since
vitro
ciliary
dyskinesia
factor
previously
demonstrated
pulmonary
complications
hallmark
cf
yet
clearance
clinically
stable
cf
subjects
relatively
well
maintained
suggested
us
mucociliary
transport
abnormality
might
present
intermittently
order
explore
designed
nasal
mucociliary
clearance
studies
determine
whether
cf
serum
might
exhibit
mct
inhibition
vivo
studies
concluded
substance
cf
serum
capacity
slow
mct
whether
effect
cilia
via
overproduction
normal
abnormal
mucus
known
